5 results
Patients with ALS are routinely prescribed riluzole, the only registered drug for the treatment of ALS. This study will evaluate the concentration-effect relationship of riluzole (100 mg) and retigabine (300 mg) on axonal excitability measures. In…
The objective is to evaluate the efficacy and safety of two doses of masitinib (4.5 mg/kg/day and 6.0 mg/kg/day) versus matching placebo in patients diagnosed with ALS treated with Riluzole (50 mg bid).The primary objective is to demonstrate…
1) To study PPG signal characteristics in relation to circulatory arrest in patients with induced circulatory arrest. 2) To construct a PPG-based algorithm for detection of circulatory arrest based on induced circulatory arrest data in patients. 3)…
The objective of this study is to examine the effect of riluzole on the glutamate/GABA balance in the brain in patients with 22q11.2DS. The secondary objective is to examine the effects of riluzole on psychotic symptoms and cognitive functioning. In…
In this study, the Trachospray device will be evaluated with regard to blocking the airway reflexes during awake videolaryngoscopie.